Skip to content

Real-world research plan for topical analgesics in the treatment of frozen shoulder

Real-world research plan for topical analgesics in the treatment of frozen shoulder

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052375
Enrollment
Unknown
Registered
2021-10-24
Start date
2021-11-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frozen shoulder

Interventions

research group :Loxoprofen sodium gel plaster for external use
Control group :Flurbiprofen gel ointment for external use

Sponsors

The Second Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with frozen shoulder; 2. Meet the pain stage in the staging standard of frozen shoulder; 3. Those who did not take other related treatment drugs (such as oral diclofenac sodium sustained-release tablets, loxoprofen sodium tablets, etc.) within 4 weeks before screening and did not receive other treatment methods; 4. Aged 30-70 years old (including 30 years old and 70 years old); 5. Subjects voluntarily agreed to participate in this study and signed a written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients who have received relevant treatment in the past, or there may be effect indicators that may affect this study; 2. Patients with acute soft tissue injury of shoulder, infectious inflammation, fracture, dislocation, rheumatoid arthritis, etc.; 3. Patients with serious primary diseases such as diabetes, tumors, cardiovascular and cerebrovascular diseases, blood diseases, and mental illnesses; 4. Those who have a history of allergies to the drugs in this study in the past; 5. Other situations in which the investigator considers it inappropriate to participate in this trial.

Design outcomes

Primary

MeasureTime frame
Pain Index Score;Shoulder CMS Score;

Secondary

MeasureTime frame
Application satisfaction;Adverse event rate;

Countries

China

Contacts

Public ContactMao Xinzhan

the Second Xiangya Hospital of Central South University

maoxinzhan72@126.com+86 13975806781

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026